The recently described infiltration of CD15 + immune cells into HPV + and p63 + PeCa specimens was prominent in the tumor center in contrast to the invasion front suggesting that the tumor immune biology at the center may impact clinical outcome and survival11,17. This evidence concerns the gene FUT4 and neoplasm.